183 related articles for article (PubMed ID: 35722901)
1. Cutaneous melanoma incidence, mortality, and survival in Manizales, Colombia: a population-based study.
Rodríguez-Betancourt JD; Arias-Ortiz N
J Int Med Res; 2022 Jun; 50(6):3000605221106706. PubMed ID: 35722901
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer incidence and patient survival in Manizales, Colombia, 2008-2012.
Benitez-Restrepo CC; Arias-Ortiz NE; Arboleda-Ruiz WA
Rev Peru Med Exp Salud Publica; 2020 Dec; 37(3):438-445. PubMed ID: 33295545
[TBL] [Abstract][Full Text] [Related]
3. Incidence, mortality and survival of endometrial cancer in Manizales, Colombia 2003-2017.
Montoya-González MC; Arias-Ortiz NE; Arboleda-Ruiz WA
Rev Peru Med Exp Salud Publica; 2021; 38(4):562-568. PubMed ID: 35385008
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study.
Guzmán-Gallego EA; Arias-Ortiz NE; Rodríguez-Betancourt JD
Rev Bras Epidemiol; 2023; 26():e230040. PubMed ID: 37729347
[TBL] [Abstract][Full Text] [Related]
5. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia Study.
Ospina Serrano AV; Contreras F; Triana I; Sánchez-Vanegas G; Ortíz JD; Ramos P; Vargas C; Arango N; Idrobo H; Munévar I; Yepes A; Mantilla W; Jiménez P; Rivas G; Lema M; Alcalá C; Gómez D; Chinchia M; Barrero A
JCO Glob Oncol; 2023 May; 9():e2200377. PubMed ID: 37216624
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Health Inequities on Population-Based Breast Cancer Survival in a Colombian Population, 2008-2015.
Arias-Ortiz N; Rodríguez-Betancourt JD; Toro-Toro JE; Navarro-Lechuga É; Jurado-Fajardo DM; Cárdenas-Garzón K; Sánchez-Vásquez GI
Cancer Control; 2024; 31():10732748241244928. PubMed ID: 38557156
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
[TBL] [Abstract][Full Text] [Related]
11. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
13. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
Ishihara K; Saida T; Otsuka F; Yamazaki N;
Int J Clin Oncol; 2008 Feb; 13(1):33-41. PubMed ID: 18307017
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
15. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
16. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
17. Trends in cancer incidence and mortality in Manizales, Colombia, 2008-2017.
Arias-Ortiz N; Rodríguez-Betancourt JD
Colomb Med (Cali); 2022; 53(1):e2044920. PubMed ID: 36415595
[TBL] [Abstract][Full Text] [Related]
18. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological profile of primary cutaneous melanoma over a 15-year period at a private skin cancer center in Colombia.
Pozzobon FC; Acosta AE
Rev Salud Publica (Bogota); 2018; 20(2):226-231. PubMed ID: 30570006
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
